New Delhi: The central government’s Subject Expert Committee (SEC) is likely to meet on Wednesday on drugmaker Dr. Reddy’s application seeking emergency use authorisation for the Sputnik V vaccine in India. If the SEC gives a nod, Sputnik V will be India’s third vaccine after Covaxin and Covishield, News18 reported.
Dr. Reddy’s has partnered with the Sputnik V vaccine to run clinical trials in India. It had submitted the immunogenicity data after a meeting that was held on February 24.
Dr Reddy’s has partnered with Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. The Russian vaccine has shown an efficacy of 91.6 %.
Bhubaneswar: Astronaut Sunita Williams feels that residents of planet Earth take small things in life a…
Bhubaneswar: At a time when he should have been grieving the loss of his son, Kailash…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi will receive the people's complaints in his grievance…
Mumbai: Actress Radhika Apte, who has been married to British composer Benedict Taylor since 2012,…
Mumbai: Kangana Ranaut’s ‘Emergency’ has finally been passed by the Central Board of Film Certification…
Bhubaneswar: In the wake of some habisyalis staging a protest for being denied free accommodation…
Mumbai: Shah Rukh Khan, the self-made superstar of Bollywood, received the Lifetime Achievement Award at…
Bengaluru: It was a clear error in judgment which resulted in Team India’s ignominous batting show…